SonaCare Medical's HIFU device is used by Dr. Kar in first Sonablate® procedure at the miVIP Surgery Center, the fifth location in the United States to perform a HIFU prostate tissue ablation with Sonablate post FDA clearance

Charlotte, NC (PRWEB) December 15, 2015 -- SonaCare Medical, LLC, the leading manufacturer of urologic HIFU technology and the first to receive FDA regulatory authorization for the ablation of prostate tissue, has announced the fifth location in the United States to perform a Sonablate® procedure post FDA clearance. The miVIP Surgery Center, in Tustin, California, installed Sonablate® in mid-November and its leading physician, Dr. Ashok Kar, performed the center’s first U.S.-based prostate tissue ablation procedure this past weekend on December 12th.

Sonablate® continues to gain momentum as the preferred prostate tissue ablation device in the United States

CHARLOTTE, N.C., December 11, 2015 -- SonaCare Medical, LLC announces that Dr. Inderbir Gill performed two Sonablate® prostate tissue ablation procedures yesterday, December 10th, at Keck Medicine of USC. With the launch of University of Southern California's urologic HIFU program, Keck Medicine of USC becomes the first academic medical center in the United States to provide this pioneering technology since the FDA granted Sonablate® de novo clearance this past October for the ablation of prostate tissue.

Dr. Stephen Scionti launches his U.S.-based prostate HIFU program in Sarasota, Florida by performing two HIFU procedures on the same day.

CHARLOTTE, N.C., DECEMBER 08, 2015 -- SonaCare Medical, LLC reports that two Sonablate® HIFU procedures were performed on Friday, December 4th, by Dr. Stephen Scionti in Sarasota, Florida. Dr. Scionti is collaborating with Vituro Health to bring their HIFU treatment program to the Sarasota Interventional Radiology Center.  This facility becomes the third location, among six systems installed to date, to perform a Sonablate® HIFU prostate tissue ablation procedure in the United States since the device received regulatory authorization in October. Dr. Scionti and team have another procedure scheduled for today, and plan to have ten performed before December 25th.

UCLH recognized for their advancements in prostate cancer diagnosis and treatment methods.

CHARLOTTE, N.C., DECEMBER 01, 2015 -- SonaCare Medical congratulates the University College London Hospitals NHS Foundation Trust on receiving the 2015 HSJ Acute Sector Innovation Award on November 18th. This prestigious award recognizes annually organizations that cultivate truly innovative methods of improving the patient care experience, and propose exciting enhancements to the medical landscape.

Michael J. Lazar, MD is the first physician to offer the recently FDA-cleared Sonablate® prostate tissue ablation procedure for men in San Francisco, CA.

CHARLOTTE, N.C., NOVEMBER 24, 2015 -- SonaCare Medical, LLC announces that a second location in the United States has performed a prostate tissue ablation procedure using the company's Sonablate® High Intensity Focused Ultrasound (HIFU) technology which FDA granted regulatory authorization for on October 9, 2015.

Page 3 of 9

HIFU company


10130 Perimeter Pkwy, Suite 250
      Charlotte, NC 28216

(888) 874-4384

Mon - Fri: 9:00 - 5:00

Latest News

23 May 2017

C-code goes into effect on July 1, 2017 affording greater opportunity to prostate patients in the United States Charlotte, NC, May 23, 2017 – SonaCare Medical, leading developer and manufacturer...

11 April 2017

Charlotte, NC (PR Newswire) April 11th, 2017 - SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the launch of an International Sonablate HIFU...